Luis
Madero Lopez
Hospital Universitario La Fe
Valencia, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario La Fe (22)
2022
2020
2018
-
Management and outcome of children and adolescents with non-medulloblastoma CNS embryonal tumors in Spain: room for improvement in standards of care
Journal of Neuro-Oncology, Vol. 137, Núm. 1, pp. 205-213
2017
-
Early clinical trials in paediatric oncology in Spain: a nationwide perspective
Anales de Pediatria, Vol. 87, Núm. 3, pp. 155-163
2016
-
Landscape of early clinical trials for childhood and adolescence cancer in Spain
Clinical and Translational Oncology, Vol. 18, Núm. 7, pp. 708-713
2013
-
Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: A joint ITCC and SIOPE brain tumor study
Neuro-Oncology, Vol. 15, Núm. 9, pp. 1236-1243
2012
-
Outcome of antifungal combination therapy for invasive mold infections in hematological patients is independent of the chosen combination
Mediterranean Journal of Hematology and Infectious Diseases, Vol. 4, Núm. 1
2011
-
Chromosome fragility in patients with Fanconi anaemia: Diagnostic implications and clinical impact
Journal of Medical Genetics, Vol. 48, Núm. 4, pp. 242-250
-
Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 6, pp. 435-454
-
Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) guidelines for the diagnosis of invasive fungal infections. 2010 Update
Enfermedades Infecciosas y Microbiologia Clinica
-
Update on bacteraemia in oncology and hematology
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. SUPPL. 4, pp. 48-53
2009
-
Compassionate use study of caspofungin in children with proven or suspected invasive mycosis or persistent febrile neutropenia
Journal of Chemotherapy, Vol. 21, Núm. 2, pp. 229-231
-
KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia
Leukemia, Vol. 23, Núm. 3, pp. 492-500
2008
-
Full breastfeeding and paediatric cancer
Journal of Paediatrics and Child Health, Vol. 44, Núm. 1-2, pp. 10-13
-
Update on pulmonary infections in patients with hematologic malignancies and hematopoietic stem cell recipients
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. SUPPL. 3, pp. 58-71
2005
-
Long-term outcome of allogeneic PBSC transplantation in pediatric patients with hematological malignancies: A report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON) and the Spanish Group for Allogeneic Peripheral Blood Transplantation (GETH)
Bone Marrow Transplantation, Vol. 36, Núm. 9, pp. 781-785
-
Long-term outcome of allogeneic or autologous haemopoietic cell transplantation for acute lymphoblastic leukaemia in second remission in children. GETMON experience 1983-1998
Bone Marrow Transplantation, Vol. 35, Núm. 9, pp. 895-901
-
Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: A multicenter study by the PETHEMA Group
Journal of Clinical Oncology, Vol. 23, Núm. 30, pp. 7632-7640
2004
-
Risk assessment and outcome of chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell transplantation in pediatric patients
Bone Marrow Transplantation, Vol. 34, Núm. 5, pp. 433-438
2002
-
Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia
Blood, Vol. 100, Núm. 12, pp. 3877-3886